The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
STATE OF THE ART
Transcatheter treatment for tricuspid valve disease
This State-of-the-Art - by F. Praz et al - reviews the available transcatheter therapies, main criteria for patient and device selection, remaining uncertainties, and future directions
November 19, 2021
NEW ISSUE
PCR London Valves Edition: state of the art on transcatheter treatment for tricuspid valve disease, a mini focus on TR; coronary access after TAVI and more…
November 19, 2021
NEWS
EuroIntervention is now on Instagram
November 29, 2021
AHEAD OF PRINT
Long-term impact of OCT-assessed suboptimal stent deployment
Francesco Prati et al.
November 25, 2021
EDITORIAL
Percutaneous tricuspid valve annuloplasty: additional data and remaining questions
Nicole Karam et al.
November 23, 2021
EDITORIAL
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?
Josep Rodés-Cabau et al.
November 23, 2021
CONSENSUS
Guidelines, consensus & position papers
consult the most recent published guidelines, consensus and position papers
November 29, 2021

The editor's choice

STATE OF THE ART
Transcatheter treatment for tricuspid valve disease
Fabien Praz
Praz F et al
October 20, 2021
10.4244/EIJ-D-21-00695
STATE OF THE ART
Valve-in-valve TAVI: a practical overview
Giuseppe Tarantini
Tarantini G et al
November 18, 2021
10.4244/EIJ-D-21-00157
STATE OF THE ART
Glucose-lowering therapy in patients undergoing percutaneous coronary intervention
Isabelle Johansson
Johansson I et al
November 15, 2021
10.4244/EIJ-D-20-01250
STATE OF THE ART
Robotics, imaging, and artificial intelligence in the catheterisation laboratory
Patrick Serruys
Serruys P, Marco J
November 22, 2021

Latest articles

Embolisation of a prosthetic mitral valve fragment during valve-in-valve transcatheter mitral valve implantation
Alnsasra H, Koifman E, Abu-Salman A, Kobal S, Cafri C
November 30, 2021 | 10.4244/EIJ-D-21-00630
Coronary interventions
Clinical outcomes of suboptimal stent deployment as assessed by optical coherence tomography: long-term results of the CLI-OPCI registry
Prati F, Romagnoli E, Biccirè FG, Burzotta F, La Manna A, Budassi S, Ramazzotti V, Albertucci M, Fabbiocchi F, Sticchi A, Trani C, Calligaris G, Fineschi M, Versaci F, Tamburino C, Ozaki Y, Alfonso F, Mintz G
November 25, 2021 | 10.4244/EIJ-D-21-00627
Interventions for stroke
Percutaneous left atrial appendage closure in a surgically ligated left atrial appendage
Wong I, Vejlstrup N, Bieliauskas G, Søndergaard L, De Backer O
November 24, 2021 | 10.4244/EIJ-D-21-00624
Interventions for valvular disease
Transcatheter edge-to-edge repair of severe calcific mitral regurgitation facilitated by balloon lithotripsy
Fam N, Hagemeyer D, Merdad A, Bisleri G, Ong G
November 24, 2021 | 10.4244/EIJ-D-21-00828
The PCR London Valves edition with a EuroIntervention State of the Art on transcatheter treatment for tricuspid valve disease; a mini focus on tricuspid regurgitation including tricuspid valve annuloplasty with the Cardioband system, tricuspid valve implantation using the novel LuX-Valve, and the impact of MitraClip mitral valve repair on tricuspid regurgitation; an expert review on coronary access after TAVI, valve-in-valve outcomes with or without bioprosthetic valve fracture, redo TAVI; and more…
Capodanno D
November 19, 2021
Percutaneous tricuspid valve annuloplasty: additional data and remaining questions
Karam N, Hausleiter J
November 19, 2021 | 10.4244/EIJV17I10A134
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?
Rodés-Cabau J, Alperi A
November 19, 2021 | 10.4244/EIJV17I10A135
Understanding the past, getting prepared for the future. (Going from in vivo to in vitro to in silico)
Serruys P, Elkoumy A, Soliman O
November 19, 2021 | 10.4244/EIJV17I10A136
Transcatheter treatment for tricuspid valve disease
Praz F, Muraru D, Kreidel F, Lurz P, Hahn R, Delgado V, Senni M, von Bardeleben R, Nickenig G, Hausleiter J, Mangieri A, Zamorano J, Prendergast B, Maisano F
November 19, 2021 | 10.4244/EIJ-D-21-00695
Thirty-day outcomes of the Cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study
Nickenig G, Friedrichs K, Baldus S, Arnold M, Seidler T, Hakmi S, Linke A, Schäfer U, Dreger H, Reinthaler M, von Bardeleben R, Möllmann H, Weber M, Roder F, Körber M, Landendinger M, Wolf F, Alessandrini H, Sveric K, Schewel D, Romero-Dorta E, Kasner M, Dahou A, Hahn R, Windecker S
November 19, 2021 | 10.4244/EIJ-D-21-00300
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation
Sun Z, Li H, Zhang Z, Li Y, Zhang L, Xie Y, Han Z, Wang J, Chen Y, Yang Y, Lv Q, Xie M
November 19, 2021 | 10.4244/EIJ-D-21-00095
Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair
Kavsur R, Iliadis C, Spieker M, Brachtendorf B, Tiyerili V, Metze C, Horn P, Baldus S, Kelm M, Nickenig G, Pfister R, Westenfeld R, Becher M
November 19, 2021 | 10.4244/EIJ-D-20-01094
Coronary artery cannulation after transcatheter aortic valve implantation
Valvo R, Costa G, Tamburino C, Barbanti M
November 19, 2021 | 10.4244/EIJ-D-21-00158
Outcomes of valve-in-valve transcatheter aortic valve implantation with and without bioprosthetic valve fracture
Brinkmann C, Abdel-Wahab M, Bedogni F, Bhadra O, Charbonnier G, Conradi L, Hildick-Smith D, Kargoli F, Latib A, Van Mieghem N, Mylotte D, Landes U, Pilgrim T, Stripling J, Taramasso M, Tchétché D, Testa L, Thiele H, Webb J, Windecker S, Witt J, Wohlmuth P, Schofer J
November 19, 2021 | 10.4244/EIJ-D-21-00254
Repeat transcatheter aortic valve implantation and implications for transcatheter heart valve performance: insights from bench testing
Sathananthan J, Fraser R, Landes U, Rich C, Sellers S, Leipsic J, Blanke P, Lutter G, Frank D, Puehler T, Wood D, Søndergaard L, Webb J
November 19, 2021 | 10.4244/EIJ-D-20-00697
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke